United States - English - NLM (National Library of Medicine)

rw consumer products ltd - zinc carbonate (unii: eqr32y7h0m) (zinc cation - unii:13s1s8sf37), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - • dries the oozing and weeping of poison • ivy • oak • sumac

United States - English - NLM (National Library of Medicine)

rw consumer products ltd - zinc carbonate (unii: eqr32y7h0m) (zinc cation - unii:13s1s8sf37), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - - dries the oozing and weeping effects of poison ivy, poison oak, and sumac

United States - English - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - zinc carbonate (unii: eqr32y7h0m) (zinc cation - unii:13s1s8sf37) - tonsilitis condition listed above or as directed by the physician

United States - English - NLM (National Library of Medicine)

hospira, inc. - zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc 1 mg/ml (zinc chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms. none known. none known.

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - zinc carbonate (unii: eqr32y7h0m) (zinc cation - unii:13s1s8sf37) -

United States - English - NLM (National Library of Medicine)

gentell, inc,. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 0.2 kg in 1 kg - helps treat & prevent diaper rash. protects chafed skin assoicated with diaper rash & helps protect from wetness. effective for treating poison ivy, poison oak & sumac. helps, treats and prevents diaper rash. protects chafed skin associaed with diaper rash & helps protect from wetness. effective in treating poison ivy, poison oak and sumac.

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate anhydrous (unii: 0j6z13x3wo) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc sulfate injection, usp is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain plasma levels and to prevent depletion of endogenous stores. zinc sulfate injection, usp should not be given undiluted by direct injection into a peripheral vein because of the likelihood of infusion phlebitis and the potential to increase renal loss of zinc from a bolus injection.

United States - English - NLM (National Library of Medicine)

chain drug manufacturing assn - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - zinc gluconate 1 [hp_x]

United States - English - NLM (National Library of Medicine)

exela pharma sciences,llc - zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37) - plastic vial rx only zinc chloride injection, usp, 1 mg/ml is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms. none known. none known.

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37) - zinc sulfate injection is indicated in adult and pediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. zinc sulfate injection is contraindicated in patients with known hypersensitivity to zinc [see warnings and precautions (5.6)] risk summary administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with intravenous zinc sulfate.  the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown.  all pregnancies have a background risk of birth defect, loss, or other adverse outcomes.  in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. clinical considerations disease-associated maternal and/or embryo-fetal risk deficiency of trace elements, including zinc, is associated with adverse pregnancy and fetal outcomes. pregnant women have an increased metabolic demand for trace elements, including zinc.  parenteral nutrition with zinc should be considered if a pregnant woman’s nutritional requirements cannot be fulfilled by oral or enteral intake. risk summary zinc is present in human milk. administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause harm to a breastfed infant. there is no information on the effects of zinc sulfate on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for zinc sulfate injection and any potential adverse effects on the breastfed infant from zinc sulfate injection or from the underlying maternal condition. zinc sulfate injection is approved for use in the pediatric population, including neonates, as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. safety and dosing recommendations in pediatric patients are based on published literature describing controlled studies of zinc-containing products in pediatric patients [see dosage and administration (2.2)] . because of immature renal function, preterm infants receiving prolonged parenteral nutrition treatment with zinc sulfate injection may be at higher risk of aluminum toxicity [see warnings and precautions (5.3)] . reported clinical experience with intravenous zinc sulfate has not identified a difference in zinc requirements between elderly and younger patients.  in general, dose selection should be individualized based on the patient’s clinical condition, nutritional requirements, and additional nutritional intake provided orally or enterally to the patient.